In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum

被引:119
作者
Croci, T
Manara, L
Aureggi, G
Guagnini, F
Rinaldi-Carmona, M
Maffrand, JP
Le Fur, G
Mukenge, S
Ferla, G
机构
[1] Res Ctr Sanofi Midy, I-20137 Milan, Italy
[2] Hosp San Raffaele, I-20132 Milan, Italy
[3] Sanofi Rech, F-31036 Toulouse, France
[4] Sanofi Rech, F-75374 Paris, France
[5] Sanofi Rech, F-34184 Montpellier, France
关键词
cannabinoids; CB1; receptors; WIN-55212-2; SR; 141716; 144528; human ileum;
D O I
10.1038/sj.bjp.0702190
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We investigated the effect of the cannabinoid agonist (+)WIN-55212-2 on human ileum longitudinal smooth muscle preparations, either electrically stimulated or contracted by carbachol. Electrical field stimulation mostly activated cholinergic neurons, since atropine and tetrodotoxin (TTX), alone or coincubated, reduced twitch responses to a similar degree (85%). (+)WIN-55212-2 concentration-dependently inhibited twitch responses (IC50 73 nM), but had no additive effect with atropine or TTX. The cannabinoid CB1 receptor antagonist SR 141716 (pA(2) 8.2), but not the CB2 receptor antagonist, SR 144528, competitively antagonized twitch inhibition by (+)WIN-55212-2. Atropine but not (+)WIN-55212-2 or TTX prevented carbachol-induced tonic contraction. These results provide functional evidence of the existence of prejunctional cannabinoid CB1-receptors in the human ileum longitudinal smooth muscle. Agonist activation of these receptors prevents responses to electrical field stimulation, presumably by inhibiting acetylcholine release. SR 141716 is a potent and competitive antagonist of cannabinoid CBI receptors naturally expressed in the human gut.
引用
收藏
页码:1393 / 1395
页数:3
相关论文
共 15 条
  • [1] SOME QUANTITATIVE USES OF DRUG ANTAGONISTS
    ARUNLAKSHANA, O
    SCHILD, HO
    [J]. BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1959, 14 (01): : 48 - 58
  • [2] Calignano A, 1997, EUR J PHARMACOL, V340, pR7
  • [3] Cannabinoid modulation of intestinal propulsion in mice
    Colombo, G
    Agabio, R
    Lobina, C
    Reali, R
    Gessa, GL
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 344 (01) : 67 - 69
  • [4] Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus
    Coutts, AA
    Pertwee, RG
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (08) : 1557 - 1566
  • [5] Cannabinoid receptors and their endogenous agonists
    Felder, CC
    Glass, M
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1998, 38 : 179 - 200
  • [6] GESSA GL, 1997, EUR J PHARMACOL, V327, pR1
  • [7] HERKENHAM M, 1995, CANNABINOID RECEPTOR, P145
  • [8] IZZO AA, 1998, BRIT J PHARMACOL, V284, P241
  • [9] Further evidence for the presence of cannabinoid CBI receptors in guinea-pig small intestine
    Pertwee, RG
    Fernando, SR
    Nash, JE
    Coutts, AA
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (08) : 2199 - 2205
  • [10] PHARMACOLOGICAL CHARACTERIZATION OF 3 NOVEL CANNABINOID RECEPTOR AGONISTS IN THE MOUSE ISOLATED VAS-DEFERENS
    PERTWEE, RG
    GRIFFIN, G
    LAINTON, JAH
    HUFFMAN, JW
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 284 (03) : 241 - 247